Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „analysis“
Suchtreffer
Begriffe & Kennungen
Brilique · 4.8 · Table 2 – Analysis of overall bleeding events, Kaplan-Meier estimates at 12 months (PLATO)
Eintrag öffnenBrilique · 4.8 · Table 2 – Analysis of overall bleeding events, Kaplan-Meier estimates at 12 months (PLATO)
Eintrag öffnenBrilique · 4.8 · Table 3 – Analysis of overall bleeding events, Kaplan-Meier estimates at 36 months (PEGASUS)
Eintrag öffnenBrilique · 4.8 · Table 3 – Analysis of overall bleeding events, Kaplan-Meier estimates at 36 months (PEGASUS)
Eintrag öffnenBrilique · 4.8 · Table 3 – Analysis of overall bleeding events, Kaplan-Meier estimates at 36 months (PEGASUS)
Eintrag öffnenBrinavess · 4.8 · The adverse reaction profile presented below is based on the analysis of pooled clinical trials, a post-author
Eintrag öffnenCabazitaxel Accord · 4.8 · Cardiac disorders and arrhythmias In the pooled analysis, cardiac events were reported in 5.5% of the patients
Eintrag öffnenCabazitaxel Accord · 4.8 · Haematuria In the pooled analysis, haematuria all grades frequency was 18.8% at 25 mg/m2 (see section 5.1). Co
Eintrag öffnenCabazitaxel Accord · 4.8 · Other laboratory abnormalities In pooled analysis, the incidence of grade ≥3 anaemia, increased AST, ALT, and
Eintrag öffnenCabazitaxel Accord · 4.8 · The incidences from the pooled analysis of these 3 trials are presented below and in the tabulated list. The m
Eintrag öffnenCapecitabine Accord · 4.8 · 17 The results of a meta-analysis of 14 clinical trials with data from over 4700 patients treated with capecit
Eintrag öffnenCapecitabine Accord · 4.8 · A meta-analysis of 14 clinical trials with data from over 4700 patients treated with capecitabine monotherapy
Eintrag öffnenCapecitabine Accord · 4.8 · Elderly patients (see section 4.2) An analysis of safety data in patients ≥ 60 years of age treated with capec
Eintrag öffnenCapecitabine Accord · 4.8 · Encephalopathy In addition to the ADRs described in tables 4 and 5, and based on the above pooled analysis fro
Eintrag öffnenCapecitabine Accord · 4.8 · Gender The results of a meta-analysis of 14 clinical trials with data from over 4700 patients treated with cap
Eintrag öffnenCapecitabine Accord · 4.8 · Patients with renal impairment (see section 4.2, 4.4, and 5.2): An analysis of safety data in patients treated
Eintrag öffnenCapecitabine Accord · 4.8 · The results of a meta-analysis of 14 clinical trials with data from over 4700 patients treated with capecitabi
Eintrag öffnenCapecitabine Teva · 4.8 · A meta-analysis of 14 clinical trials with data from over 4700 patients treated with capecitabine monotherapy
Eintrag öffnenCapecitabine Teva · 4.8 · An analysis of safety data in patients treated with capecitabine monotherapy (colorectal cancer) with baseline
Eintrag öffnenCapecitabine Teva · 4.8 · An analysis of safety data in patients ≥60 years of age treated with capecitabine monotherapy and an analysis
Eintrag öffnen